CEBPZ and acute myeloid leukemia: Here we report the case of a CBF-AML patient with KIT p.D816V mutation who failed avapritinib induction therapy and subsequently underwent bridging allogeneic hematopoietic stem cell transplantation(allo-HSCT), along with a literature review.